This content is only available within our institutional offering.

04 Aug 2022
Hikma Pharmaceuticals (Buy) - 1H22 in line but guidance changes: Generics cut by c.10%

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (Buy) - 1H22 in line but guidance changes: Generics cut by c.10%
Hikma Pharmaceuticals Plc (HIK:LON) | 1,836 275.4 0.8% | Mkt Cap: 4,074m
- Published:
04 Aug 2022 -
Author:
Miles Dixon -
Pages:
5 -